Key result
Echocardiographic reverse remodelling after cardiac resynchronization therapy was substantially stronger among patients with left bundle branch block and QRS width ≥150 ms.
Why the study?
Does cardiac resynchronization therapy improve echocardiographic reverse remodelling in heart failure patients depending on QRS morphology and width?
Does cardiac resynchronization therapy improve echocardiographic reverse remodelling in heart failure patients depending on QRS morphology and width?
Answers are grounded in this paper and cite their sources.
This editorial highlights that while CRT generally induces greater reverse remodeling in heart failure patients with LBBB and QRS ≥150 ms, individual responses vary significantly, emphasizing the need for tailored patient selection.
This article refers to ‘Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy’, by P. van der Bijl et al., published in this issue on pages 1145–1151. In this issue van der Bijl et al. demonstrate that evidence of echocardiographic reverse remodelling after cardiac resynchronization therapy (CRT) was substantially stronger among patients with left bundle branch block (LBBB) compared with patients with non-LBBB morphology. The findings were similar when comparing patients with a QRS width of ≥150 ms vs. <150 ms with greater volume reductions and improvements in ejection fraction in the patients with the wider QRS complexes.1 These are encouraging findings for clinicians and further confirm and extend our established knowledge concerning selection of appropriate patients for CRT. The interpretation of the available data accumulated during the last two decades is consistent: CRT works best in patients with LBBB morphology combined with a wide QRS complex. The favourable response includes both echocardiographic indices of functional improvement (reverse remodelling)2, 3 and improvement in terms of major clinical outcomes.4-6 This knowledge was established by a large number of randomized clinical trials, and subgroup- and meta-analyses, and forms the basis for the strong indications for CRT in the 2016 ESC guidelines,7 which emphasize the importance of QRS morphology and duration in the selection of patients. The present, retrospective, observational study was performed on a large, ‘real world’ clinical registry at an institution with recognized expertise in echocardiography as well as long-term experience in CRT. The cohort consisted of 1467 patients with heart failure and a wide range of QRS durations and morphologies. Fifty-five per cent had LBBB. Echocardiography was performed as part of a routine registry protocol before and 6 months after CRT implantation. The authors do not state whether the echocardiography measurements were taken by blinded observers to reduce bias, whether a core laboratory evaluation was made, or whether repeated measurements were done to increase precision. The authors state that the CRTs were implanted according to clinical decisions and current guidelines. The mean QRS duration for the entire cohort was 156 ms with a standard deviation of 33 ms. QRS durations for each of the patient groups were not presented. The figures, presented as scattergrams, are elegant, informative, and permit rapid digestion of the data. It is evident from Figure 3 that many of the patients had considerably shorter QRS duration than the 130 ms that is now considered the lower limit of a IA guideline recommendation,7 and, in some patients, even shorter than the previous limit of 120 ms. So, when selecting patients for CRT, it is evident that implanters sometimes included patients into the registry that did not have a strong indication. It has been reported earlier that clinicians often may decide to implant a CRT in patients with less evidenced-based clinical data.8 For example, patients with atrial fibrillation, patients with modest symptoms, a narrow QRS complex, or to prevent progression of heart failure in atrioventricular block with expected pacemaker dependence. Figure 3 also illustrates a clear tendency that non-LBBB patients had the narrowest but also some of the widest QRS complexes. The LBBB subjects tended to populate the mid-range. It has been argued that a genuine LBBB rarely has a shorter QRS duration than 130 ms in women and 140 ms in men.9 The patients were grouped according to QRS <150 ms or ≥150 ms and morphology either being LBBB or non-LBBB, and compared. Sophisticated statistics (linear mixed models) were also used to analyse the effect of QRS duration and morphology on echocardiographic outcome. The findings demonstrate that the evidence for reverse remodelling was substantially stronger in subjects with LBBB and/or with a wider QRS, within certain limits. These conclusions emerge from the advanced statistical analyses based on a large number of subjects and dichotomization of the continuous variables left ventricular ejection fraction (LVEF) and QRS duration. This is good scientific practice and is not a limitation unique to this work. However, a plot of individual data often gives a clearer picture. Figures 1, 2, and 3 may be considered the study in a nutshell. If you only have a few minutes, spend them on these figures. For example, Figure 3 is a plot of QRS duration against changes in LVEF, which provides important information in addition to, and beyond, the advanced statistics. Firstly, on average for the entire group, LVEF increased during the observation period, regardless of QRS morphology and duration. Since this study, in contrast to some of the previous controlled studies,2-5 did not have a control group of ‘no CRT’ or ‘CRT off’, we do not know if changes in LVEF were due to CRT or to something else, such as regression or progression of the underlying disease, altered medication during specialist follow-up, observer bias in the echocardiographic measurements, or to the statistical phenomenon called ‘regression towards the mean’. Secondly, the figure illustrates an important limitation inherent in this type of research. The scattergram looks like someone fired a shotgun targeting slightly above and to the right of the centre made by the two dichotomized variables. If we assume that only a limited amount of the scatter is due to measurement imprecision, this illustrates two important points: (i) certain patients with a QRS <100 ms could also have a remarkable increase in LVEF after being implanted with a CRT, for some reason or another, and (ii) LVEF could worsen considerably even if the QRS was >150 ms and the morphology LBBB. The above points are also relevant for interpreting Figures 1 and 2, which are equally informative and present the data on volume change as a measure of CRT efficacy according to QRS width. Some patients with a narrow complex may exhibit meaningful reductions in systolic and diastolic volumes. Data that are valid on a group basis may not reliably predict the outcome of an individual patient. But this does not allow us to infer from the present study that CRT will also benefit a patient with a narrow QRS and/or a non-LBBB morphology. This is a crucial insight for clinicians considering evidence-based guidelines when making decisions about individual patient management. In addition to QRS morphology and width, we must evaluate the patient's clinical status, risk stratification and expectations, the expertise of the implanter in performing the procedure, placing the left ventricular lead, and programming the device with an adequate follow-up plan, as well as cost-effectiveness concerns.10 Every patient requires a tailored approach and prediction of response is not an exact science. That's what makes medicine an art. Conflict of interest: none declared.
No takes yet. Share an insight, caveat, or question.
Steen et al. (2017) conducted an editorial in Heart failure (n=1,467). Left bundle branch block (LBBB) morphology and QRS width ≥150 ms vs. Non-LBBB morphology and QRS width <150 ms was evaluated on Echocardiographic reverse remodelling (changes in left ventricular ejection fraction and volume). Echocardiographic reverse remodelling after cardiac resynchronization therapy was substantially stronger among patients with left bundle branch block and QRS width ≥150 ms.
Synapse has enriched 10 related papers. Consider them for comparative context: